Nvidia's latest earnings report revealed a stunning $46.7 billion in revenue, yet the stock fell 4% post-announcement. Experts cite high expectations and ongoing geopolitical issues as potential factors behind the unexpected drop.
In a surprising move, Cracker Barrel announced it will ditch its controversial new logo and revert to its beloved 'Old Timer' design after backlash from customers and even President Trump. Stay tuned for updates!
Investors must consider 'wokeness' as a critical risk factor, as seen in Cracker Barrel's recent stock plunge following a controversial rebranding. Discover the insights that could shape your investment strategy.
As investors brace for Jerome Powell's critical speech, stocks drop across major indexes, led by declines in tech. Walmart's earnings disappointment adds to market woes. Will Powell's words change the tide?
Cracker Barrel's stock fell 10% after unveiling a new logo that removes traditional elements, sparking criticism from conservatives and social media. The change aims to modernize the brand amidst a larger refresh strategy.
Cava's stock tumbled 16% following disappointing quarterly sales, reflecting a broader trend of declining performance in the fast-casual dining sector. Executives cite cautious diners and economic uncertainty as key factors affecting sales.
UnitedHealth Group's stock continues to decline as the insurer battles rising medical costs and a challenging earnings outlook. Following the abrupt CEO change, the company anticipates no earnings growth until 2026.
Apple shares plunged 3% after President Trump threatened a 25% tariff unless iPhones are made in the U.S. Discover the implications for investors and key price levels to watch.
Shares of BYD fell on the Hong Kong exchange following recent price cuts. This move has raised eyebrows in the EV market, affecting other key players like Xpeng, Nio, and Li Auto. What does this mean for the future of electric vehicles?
In a shocking turn of events, Andrew Witty has resigned as CEO of UnitedHealth Group, triggering a 17% stock drop and raising concerns over the company's future amid rising medical costs and a recent antitrust lawsuit.
